Research progress on serine/threonine kinase PLK1
- VernacularTitle:丝/苏氨酸激酶PLK1研究进展
- Author:
Xianzhe DONG
;
Peng ZHANG
;
Minggang BI
- Publication Type:Journal Article
- Keywords:
PLK1;
mitosis;
DNA;
p53;
tumor;
immunity;
target
- From:
Chinese Pharmacological Bulletin
2010;26(3):289-293
- CountryChina
- Language:Chinese
-
Abstract:
Polo-like kinase 1(PLK1)is a serine/threonine kinase which is highly conserved, and its activity is elevated in many human tumor cell lines.Lots of reports have shown that PLK1 is critical for all stages of mitosis.The newest report finds that PLK1 is required for DNA synthesis, maintenance of DNA integrity, and prevention of cell death.PLK1 physically binds to the tumor suppressor p53 in mammalian cultured cells, and inhibits its transactivation activity as well as its function in activate checkpoint protein and its pro-apoptotic function.Also PLK1 is involved in the development of tumors, and Polo-like kinase1(PLK1)regulates IFN induction by MAVS, breakdown the innate immunity. Various of inhibitors of PLK1 show the feature of high performance and low toxicity, suggesting that PLK1 may be a feasible target for cancer therapy and immunity therapy.
